Glucose Health, Inc. balance sheet GLUC

Annual Quarterly

As of Sep 30, 2017, Glucose Health, Inc. had total assets of $26,353 and total liabilities of $452,585. Total assets were down 40.1% from a year earlier. Stockholders' equity was negative, at -$426,232, because liabilities exceed assets. Cash and investments were $16,636. The current ratio, current assets divided by current liabilities, was 0.06.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q3 FY2017 Sep 30, 2017	Q2 FY2017 Jun 30, 2017	Q1 FY2017 Mar 31, 2017	Q4 FY2016 Dec 31, 2016	Q3 FY2016 Sep 30, 2016	Q2 FY2016 Jun 30, 2016	Q1 FY2016 Mar 31, 2016	Q4 FY2015 Dec 31, 2015
Assets
Cash	0 +709.5%	0	0	0	—	—	—	0 +189.0%
Cash and investments	0 +709.5%	0	0	0	—	—	—	0 +189.0%
Receivables	0 -22.5%	0 -94.8%	0 +205.8%	0 +272.2%	0 +493.0%	0	0	0
Inventory	0 -100.0%	0 -100.0%	0 -100.0%	—	0 -33.8%	0 -28.7%	0 -33.5%	0
Total current assets	0 -40.1%	0 -86.9%	0 -63.7%	0 +117.8%	0 +110.7%	0 +919.9%	0 +37.7%	0 -65.5%
Total assets	0 -40.1%	0 -86.8%	0 -63.5%	0 +115.1%	0 +109.1%	0 +906.5%	0 +37.4%	0 -65.0%
Liabilities and equity
Total current liabilities	0 +8.4%	0 +12.5%	1 +19.3%	1 +31.1%	0 +9.1%	0 +20.8%	0 +23.0%	0 +24.2%
Total liabilities	0 +8.4%	0 +12.5%	1 +19.3%	1 +31.1%	0 +9.1%	0	0 +23.0%	0 +24.2%
Stockholders' equity	-0 -14.1%	-0 -107.3%	-1 -29.9%	-0 -27.8%	-0 -3.3%	-0 +34.4%	-0 -21.3%	-0 -38.2%
Ratios
Current ratio	0.06x	0.06x	0.03x	0.06x	0.10x	0.49x	0.11x	0.04x
Return on assets	-322.78%	-968.78%	-2,174.34%	-1,238.33%	-757.84%	-106.99%	-339.58%	-1,726.90%
Book value per share	-0.09	-0.11	-0.15	-0.15	-0.12	-0.08	-0.16	-0.16

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: GLUC (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Bentonville, AR
SEC filer status: Smaller reporting company
SEC CIK: 1420108
Former names: Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.